The 8 de Marzo Pharmaceutical Company resumed the production of oral antibiotics and increased the capacities for injectables, after the delivery of about 80 tons of raw materials, as part of a contribution from the Government of India.
This was stated to the press by Xenia Madrazo Sagre, Director General of the entity, and she pointed out that the production will cover the demand of the National Health System for between six and 12 months, depending on the assortment.
The aid consisted in the delivery of ten million Euros to the Cuban Government, which were destined to the purchase of active pharmaceutical ingredients for the manufacture of antibiotics.
Madrazo Sagre said that these products are destined to community and hospital pharmacies. In the case of oral antibiotics, he explained that the first delivery is expected to be made within 45 days, given that these raw materials must undergo a physical-chemical and microbiological analysis before entering production, he added.
The antibiotics to be produced will be amoxicillin, cefalexin and cefixime, the latter in capsules and suspension, and the injectables ceftriaxone, cefuroxime and ceftazidime.
Mayda Mauri Pérez, president of the BioCubaFarma business group, thanked the Indian government - represented by its ambassador to the island, Armstrong Changsan - for its help, which she described as timely, taking into account the context of economic crisis in which Cuba finds itself.
He pointed out that Cuba and India have an excellent trajectory of joint work in biotechnological development, from the contribution of equipment, technology transfer, joint productions, among others.
Ambassador Armstrong Changsan expressed that it is the first time that his country donates active pharmaceutical ingredients to another nation; however, they are very proud to be able to contribute and show their support for the benefit of the health and welfare of the Cuban people. "I am confident that our mutual friendship and support will remain strong and grow further," he said.
